Phase 3 PCDH19 Epilepsy Study Announced

According to a story from Market Screener, the biopharmaceutical company Marinus Pharmaceuticals, Inc. recently announced its plans to initiate a Phase 3 study that is intended to test ganaxolone as…

Continue Reading Phase 3 PCDH19 Epilepsy Study Announced